Konstantinos Syrigos to Retreatment
This is a "connection" page, showing publications Konstantinos Syrigos has written about Retreatment.
Connection Strength
0.084
-
A phase II study of nab-paclitaxel and carboplatin chemotherapy plus necitumumab in the first-line treatment of patients with stage IV squamous non-small cell lung cancer. Lung Cancer. 2019 10; 136:52-56.
Score: 0.048
-
Cabazitaxel Versus Topotecan in Patients with Small-Cell Lung Cancer with Progressive Disease During or After First-Line Platinum-Based Chemotherapy. J Thorac Oncol. 2015 Aug; 10(8):1221-8.
Score: 0.036